comparemela.com
Latest Breaking News On - Epidys - Page 1 : comparemela.com
FDA Extends Review Time for Investigational Duchenne Agent Givinostat
Givinostat, a histone deacetylase inhibitor from Italfarmaco, was supported by data from the phase 3 EPIDYS study, a randomized, double-blind, placebo-controlled, multicenter trial investigating the agent vs placebo.
Paolo-bettica
Italfarmaco-paolo-bettica
Craig-mcdonald
Department-of-pediatrics
Uc-davis-health
Uc-davis-health-craig-mcdonald
Prescription-drug-user-fee-act
North-star-ambulatory-assessment
Physical-medicine
Epidys
Italfarmaco
Givinostat
vimarsana © 2020. All Rights Reserved.